
TOMI Environmental Solutions (NASDAQ:TOMZ) reported its first positive quarterly operating income in two years as third-quarter revenue rose 24% from a year earlier. Management maintained its goal of $12 million in 2026 sales while cautioning that its broader sales pipeline consists of potential business rather than committed orders.
The disinfection and decontamination company reported approximately $2.49 million in third-quarter revenue, up from $2.01 million a year earlier and $2.25 million in the second quarter. Operating income was approximately $30,000, compared with an operating loss of $321,000 in the prior-year quarter.
CEO and Chairman Dr. Halden Shane said revenue has grown sequentially throughout 2026, with third-quarter sales approximately 51% above the first quarter. The positive operating result was the company’s first since the third quarter of 2024.
Product Sales Drive Growth
Product revenue increased approximately 30% year over year to $2.08 million in the third quarter, while U.S. revenue rose 50% to approximately $1.92 million, Chief Financial Officer Niro Srirathan said. For the first nine months of 2026, total revenue rose 38% to approximately $6.39 million, including 61% growth in product revenue.
Third-quarter gross profit rose 19% to approximately $1.47 million, while operating expenses fell 7% to approximately $1.44 million. Srirathan attributed the expense decline in part to lower general and administrative costs, despite elevated professional and consulting expenses associated with strategic and financing activities.
Shane said delivered sales of the company’s BIT Solution consumable so far this year, combined with open orders, had surpassed sales for all of 2025. Mobile equipment sales on the same basis were almost 107% above last year’s full total, he said.
Accounting Review and Financing
TOMI and its independent registered public accounting firm have not completed a review of the accounting treatment for the company’s convertible notes, including the conversion of $2.5 million of notes during the third quarter. As a result, management did not discuss figures that could be affected, including net loss, loss per share and related liability and stockholders’ equity balances.
Shane said the company expects any impact of the accounting treatment to be noncash and does not expect the review to affect revenue, gross profit, operating expenses or operating income. All results remain subject to change until TOMI files its quarterly report on Form 10-Q, he said.
Working capital increased to approximately $1.95 million from $1.02 million at the end of 2025. Asked whether working capital could constrain growth, Shane said the company was discussing expanded credit facilities or a potential private investment in public equity offering. He added that deposits on large accounts, sometimes about 50%, help the company manage its capital needs.
Orders and 2026 Outlook
The company’s sales order backlog was approximately $2.5 million as of Sept. 30 and had since risen to about $2.8 million, Shane said. TOMI’s broader sales opportunity pipeline had a projected value of approximately $35 million, spanning opportunities from proposals through negotiations and purchasing.
“These represent potential future revenue. They’re not committed orders yet or guarantees of future performance,” Shane said.
Chief Operating Officer E.J. Shane said delivered sales plus open orders for 2026 stood at $9.3 million. Separately, the company expects approximately $5 million in additional purchase orders before year-end. Those expected orders cover several accounts, including two Custom Engineered Systems scheduled for installation in February and April 2027, he said.
In response to an analyst’s question about timing, E.J. Shane said the two custom systems were expected to be delivered in the first and second quarters of 2027, while a substantial portion of the anticipated orders involved mobile equipment. The expected purchase orders are not the same as revenue recognized in 2026.
Shane also said a nearly $1 million project involving applicators in proprietary machine lines at a multinational healthcare manufacturer was underway. The customer is expanding into additional facilities following European Union regulatory acceptances, he said.
Food Safety Efforts Face Regulatory Steps
E.J. Shane described food safety as a priority growth market, but said it was not yet a driver of revenue results. TOMI is working with Nestlé and Danone on international registrations and U.S. Food and Drug Administration food contact notifications for dairy and infant formula applications, he said.
He also cited an independent laboratory study announced in October that showed treated flat-surface samples had an average reduction of greater than seven log for a specific type of Listeria, at or below the laboratory’s detection limit.
For poultry and related food-contact uses, E.J. Shane said each component and intended use of the complete SteraMist formulation needs an applicable regulatory basis. TOMI does not yet have sufficient poultry-use residue data to support a non-detectable residue claim and is developing that data, he said.
The company has filed a new technology notification with the U.S. Department of Agriculture’s Food Safety and Inspection Service seeking a no-objection letter. E.J. Shane cautioned that such a letter would not establish antimicrobial efficacy or, by itself, authorize the use of iHP.
About TOMI Environmental Solutions (NASDAQ:TOMZ)
TOMI Environmental Solutions, Inc. develops, manufactures and commercializes environmental decontamination and infection-prevention solutions. Its primary technology, SteraMist, uses a patented Binary Ionization Technology process that converts a hydrogen peroxide solution into a fine mist intended to reduce or eliminate a broad range of pathogens on surfaces and in enclosed environments. The company offers SteraMist systems, equipment and related products for use in healthcare facilities, life sciences and pharmaceutical environments, commercial and industrial facilities, education, government and other settings that require disinfection or biodecontamination.
